propranolol glucuronide

Known as: beta-D-Glucopyranosiduronic acid, 1-(((1-methylethyl)amino)methyl)-2-(1-naphthalenyloxy)ethyl 
 

Topic mentions per year

Topic mentions per year

1979-2006
02419792006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Propranolol is a nonselective beta-adrenergic blocker used as a racemic mixture in the treatment of hypertension, cardiac… (More)
  • table 3
Is this relevant?
2004
2004
Propranolol, available commercially as a racemic mixture, is a non-selective beta-adrenergic blocking agent used in the treatment… (More)
Is this relevant?
1997
1997
We conducted an open-label study to determine the impact of cytochrome P-4502D6 (CYP2D6) on propranolol pharmacokinetics and… (More)
Is this relevant?
1989
1989
The relative contributions of the debrisoquin and mephenytoin isozymes of hepatic cytochrome P-450 to the stereoselective… (More)
Is this relevant?
1985
1985
A recent study, identifying several sulfate conjugates, appears to have led to a full qualitative account of propranolol… (More)
Is this relevant?
1984
1984
The objective of this study was to elucidate stereoselective mechanisms of propranolol metabolism in man. Five normal subjects… (More)
Is this relevant?
1983
1983
High-performance liquid chromatographic assays for propranolol and its major metabolites in plasma and breast milk are described… (More)
Is this relevant?
1983
1983
We compared propranolol with methyldopa in a randomized prospective study of 28 women with pregnancy associated hypertension… (More)
Is this relevant?
1979
1979
The comparative disposition of propranolol glucuronide (PG) and propranolol was determined in 35 patients with hypertension or… (More)
Is this relevant?
1979
1979
The relative importance of presystemic and systemic glucuronidation of propranolol was examined in normal subjects given single… (More)
Is this relevant?